Search

Author/Creator Ryoo, Baek-Yeol

1. Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial. Issue 5 (3rd May 2023)

Authors:
Jeong, Hyehyun; Kim, Kyu-pyo; Jeong, Jae Ho; Hwang, Dae Wook; Lee, Jae Hoon; Kim, Ki-Hun; Moon, Deok-Bog; Lee, Myung Ah; Park, Se Jun; Chon, Hong Jae; Park, Jin-hong; Lee, Ji Sung; Ryoo, Baek-Yeol; Yoo, Changhoon
Journal:
Hepatology
Issue:
Volume 77:Issue 5(2023)
Page Start:
1540
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240. (September 2021)

Authors:
Vogel, Arndt; Merle, Philippe; Verslype, Chris; Finn, Richard S.; Zhu, Andrew X.; Cheng, Ann-Lii; Chan, Stephen Lam; Yau, Thomas; Ryoo, Baek-Yeol; Knox, Jennifer; Daniele, Bruno; Qin, Shukui; Wei, Ziwen; Miteva, Yanna; Malhotra, Usha; Siegel, Abby B.; Kudo, Masatoshi
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 13(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study. Issue 6 (June 2020)

Authors:
Lee, Michael S; Ryoo, Baek-Yeol; Hsu, Chih-Hung; Numata, Kazushi; Stein, Stacey; Verret, Wendy; Hack, Stephen P; Spahn, Jessica; Liu, Bo; Abdullah, Heba; Wang, Yulei; He, Aiwu Ruth; Lee, Kyung-Hun
Journal:
Lancet oncology
Issue:
Volume 21:Issue 6(2020)
Page Start:
808
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial. Issue 8 (August 2022)

Authors:
Kelley, Robin Kate; Rimassa, Lorenza; Cheng, Ann-Lii; Kaseb, Ahmed; Qin, Shukui; Zhu, Andrew X; Chan, Stephen L; Melkadze, Tamar; Sukeepaisarnjaroen, Wattana; Breder, Valery; Verset, Gontran; Gane, Edward; Borbath, Ivan; Rangel, Jose David Gomez; Ryoo, Baek-Yeol; Makharadze, Tamta; Merle, Philipp...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 8(2022)
Page Start:
995
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Chromogranin A Expression in Rectal Neuroendocrine Tumors Is Associated With More Aggressive Clinical Behavior and a Poorer Prognosis. (November 2020)

Authors:
Kim, Jisup; Kim, Joo Young; Oh, Eun Hye; Yoo, Changhoon; Park, In Ja; Yang, Dong-Hoon; Ryoo, Baek-Yeol; Ryu, Jin-Sook; Hong, Seung-Mo
Journal:
American journal of surgical pathology
Issue:
Volume 44:Number 11(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy. (March 2021)

Authors:
Bang, Kyunghye; Cheon, Jaekyung; Jeong, Jae Ho; Im, Hyeon-Su; Kim, Kyu-pyo; Ryoo, Baek-Yeol; Yoo, Changhoon
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 13(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Corrigendum to 'Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer', [Eur J Canc 51 (2015) 482–488]. (April 2021)

Authors:
Ryu, Min-Hee; Yoo, Changhoon; Kim, Jong Gwang; Ryoo, Baek-Yeol; Park, Young Soo; Park, Sook Ryun; Han, Hye-Suk; Chung, Ik Joo; Song, Eun-Kee; Lee, Kyung Hee; Kang, Seok Yun; Kang, Yoon-Koo
Journal:
European journal of cancer
Issue:
Volume 147(2021)
Page Start:
187
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17–25]. (September 2018)

Authors:
Chau, Ian; Peck-Radosavljevic, Markus; Borg, Christophe; Malfertheiner, Peter; Seitz, Jean Francois; Park, Joon Oh; Ryoo, Baek-Yeol; Yen, Chia-Jui; Kudo, Masatoshi; Poon, Ronnie; Pastorelli, Davide; Blanc, Jean-Frederic; Chung, Hyun Cheol; Baron, Ari D.; Okusaka, Takuji; Bowman, L.; Cui, Zhanglin...
Journal:
European journal of cancer
Issue:
Volume 100(2018)
Page Start:
135
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗